187 related articles for article (PubMed ID: 23253561)
1. Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children.
Rabusin M; Snowden JA; Veys P; Quartier P; Dalle JH; Dhooge C; Di Bartolomeo P; Gonzalez-Vicent M; Gibson B; Iriondo A; Juergens H; Lisukov I; Messina C; Mialou V; Steward CG; Urban C; Renard M; Giurici N; Peters C; Badoglio M; Ronfani L; Dini G; Farge D; Saccardi R;
Biol Blood Marrow Transplant; 2013 Apr; 19(4):666-9. PubMed ID: 23253561
[TBL] [Abstract][Full Text] [Related]
2. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
Passweg JR; Rabusin M; Musso M; Beguin Y; Cesaro S; Ehninger G; Espigado I; Iriondo A; Jost L; Koza V; Lenhoff S; Lisukov I; Locatelli F; Marmont A; Philippe P; Pilatrino C; Quartier P; Stary J; Veys P; Vormoor J; Wahlin A; Zintl F; Bocelli-Tyndall C; Tyndall A; Gratwohl A;
Br J Haematol; 2004 Jun; 125(6):749-55. PubMed ID: 15180864
[TBL] [Abstract][Full Text] [Related]
3. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.
Passweg JR; Rabusin M
Autoimmunity; 2008 Dec; 41(8):660-5. PubMed ID: 18958755
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disease after autologous hematopoietic stem cell transplantation.
Bohgaki T; Atsumi T; Koike T
Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Daikeler T; Hügle T; Farge D; Andolina M; Gualandi F; Baldomero H; Bocelli-Tyndall C; Brune M; Dalle JH; Urban C; Ehninger G; Gibson B; Linder B; Lioure B; Marmont A; Matthes-Martin S; Nachbaur D; Schuetz P; Tyndall A; van Laar JM; Veys P; Saccardi R; Gratwohl A;
Bone Marrow Transplant; 2009 Jul; 44(1):27-33. PubMed ID: 19139739
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
7. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
8. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
[TBL] [Abstract][Full Text] [Related]
9. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
10. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
[TBL] [Abstract][Full Text] [Related]
11. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.
Daikeler T; Kötter I; Bocelli Tyndall C; Apperley J; Attarbaschi A; Guardiola P; Gratwohl A; Jantunen E; Marmont A; Porretto F; Musso M; Maurer B; Rinaldi N; Saccardi R; Tyndall A;
Ann Rheum Dis; 2007 Feb; 66(2):202-7. PubMed ID: 16950809
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009.
Snowden JA; Pearce RM; Lee J; Kirkland K; Gilleece M; Veys P; Clark RE; Kazmi M; Abinun M; Jackson GH; Mackinnon S; Russell NH; Cook G;
Br J Haematol; 2012 Jun; 157(6):742-6. PubMed ID: 22533715
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
15. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
18. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
[TBL] [Abstract][Full Text] [Related]
19. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group.
Cesaro S; Brugiolo A; Faraci M; Uderzo C; Rondelli R; Favre C; Zecca M; Garetto G; Dini G; Pillon M; Messina C; Zanesco L; Pession A; Locatelli F
Bone Marrow Transplant; 2003 Nov; 32(9):925-31. PubMed ID: 14561994
[TBL] [Abstract][Full Text] [Related]
20. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
